Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 64M | 7.3% |
| Gross Profit | 45M | 8.6% |
| Cost of Revenue | 19M | 4.4% |
| Operating expense | 29M | 0.1% |
| Net Income | 14M | 25.1% |
| EBITDA | 22M | 21.8% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 578M | 3.9% |
| Total Liabilities | 215M | 3.1% |
| Total Equity | 363M | 4.3% |
| Shares Outstanding | 23M | 0% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | 20M | 124.5% |
| Cash from investing | -16M | 278.4% |
| Cash from financing | -2.8M | 47.2% |
EPS
Financial Highlights for LeMaitre Vascular in Q2 '25
LeMaitre Vascular reported a revenue of 64M, which is a 7.3% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 45M, marking a 8.6% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 19M, a 4.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 29M, showing a 0.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 14M, showing a 25.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 22M, showing a 21.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for LeMaitre Vascular with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
